Treatment of Polymicrobial Ankle Infection

Rationale for Current Regimen

The combination of vancomycin and piperacillin-tazobactam provides comprehensive coverage for polymicrobial infections involving both gram-positive cocci and gram-negative organisms, as recommended by the Infectious Diseases Society of America for severe skin and soft tissue infections with polymicrobial etiology 2, 3
Piperacillin-tazobactam offers broad-spectrum coverage including activity against most gram-negative bacteria, including Enterobacteriaceae, and many anaerobes that may be present in mixed infections 1
Vancomycin provides reliable coverage against gram-positive organisms including streptococcal species 1

For Group C streptococcus, vancomycin is active against most streptococcal species, though penicillin remains the drug of choice for susceptible strains, according to the Infectious Diseases Society of America 4
For Streptococcus pyogenes, vancomycin provides adequate coverage, as recommended by the Infectious Diseases Society of America 2

Vancomycin standard dosing is 15-20 mg/kg every 8-12 hours with target trough concentrations of 15-20 μg/mL in severe infections, as recommended by the Infectious Diseases Society of America 4
Piperacillin-tazobactam standard dosing is 3.375 g every 6 hours or 4.5 g every 8 hours IV, as recommended by the Infectious Diseases Society of America 2

For streptococcal infections, penicillin G or ceftriaxone may be considered as alternative regimens, as recommended by the Infectious Diseases Society of America 4
For mixed infections including coliforms, ceftriaxone plus metronidazole may be considered as an alternative regimen, as recommended by the Infectious Diseases Society of America 2

For most bacterial skin and soft tissue infections, a duration of 7-14 days is recommended, as suggested by the Infectious Diseases Society of America 5, 3
Treatment should be extended if the infection has not improved within this time period, as recommended by the Infectious Diseases Society of America 3

Obtain deep tissue cultures if possible rather than superficial swabs to guide targeted therapy, as recommended by the Infectious Diseases Society of America 3
Assess for any underlying conditions that may complicate treatment, such as diabetes or vascular insufficiency, as recommended by the Infectious Diseases Society of America 1
Evaluate for the need for surgical debridement, especially if there is concern for necrotizing infection or abscess formation, as recommended by the Infectious Diseases Society of America 2
Consider infectious disease consultation for complex polymicrobial infections, as recommended by the Infectious Diseases Society of America 1